This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-growth: Archive
Is Hennes & Mauritz (HNNMY) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Hennes & Mauritz (HNNMY) possesses solid growth attributes, which could help it handily outperform the market.
HNNMYNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy Tapestry (TPR) Now
by Zacks Equity Research
Tapestry (TPR) possesses solid growth attributes, which could help it handily outperform the market.
TPRPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Brokers Suggest Investing in Roku (ROKU): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Roku (ROKU) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ROKUNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Sea Limited (SE) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Sea Limited (SE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Howmet (HWM): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Howmet (HWM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
HWMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Celestica (CLS): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Celestica (CLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CLSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Marvell (MRVL) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Marvell (MRVL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MRVLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Bit Digital (BTBT): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Bit Digital (BTBT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
BTBTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Nutanix (NTNX): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Nutanix (NTNX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
NTNXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Commvault (CVLT): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Commvault (CVLT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CVLTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth